Peptide vaccine therapy

5 trials

Sponsors

Institute of Medical Science, University of Tokyo, University of Tokyo, Department of Gastroenterological Surgery,Graduate School of Medicine,Osaka University, Tokyo Women's Medical University

Conditions

Advanced esophageal cancer refractory to standard therapeutic modalityAdvanced gastric cancerAdvanced or recurrent gastric and colorectal cancerAdvanced or recurrent gastric cancer refractory to standard therapeutic modalityadvanced or recurrent colorectal cancer

Phase 1

Phase I clinical study of peptide vaccine using novel tumor-associated antigen TTK against advanced esophageal carcinoma

Active, not recruitingJPRN-UMIN000001014

University of TokyoAdvanced esophageal cancer refractory to standard therapeutic modality

Start: 2008-02-01Target: 6Updated: 2026-06-29

Phase I clinical study of tumor-specific vaccine using novel tumor antigen SCRN1-derived HLA*0201 restricted epitope peptide against advanced gastric cancer

Active, not recruitingJPRN-UMIN000001013

Institute of Medical Science, University of TokyoAdvanced gastric cancer

Start: 2008-01-01Target: 6Updated: 2026-06-29

PhaseI/II clinical study of peptide vaccine against advanced or recurrent gastric cancer

Active, not recruitingJPRN-UMIN000004389

Department of Gastroenterological Surgery,Graduate School of Medicine,Osaka UniversityAdvanced or recurrent gastric cancer refractory to standard therapeutic modality

Start: 2010-10-01Target: 30Updated: 2026-06-29

Unknown Phase

Phase I clinical trial of peptide vaccine with UFT/LV for advanced or recurrent colorectal cancer

Active, not recruitingJPRN-UMIN000004452

Tokyo Women's Medical Universityadvanced or recurrent colorectal cancer

Start: 2008-07-01Target: 10Updated: 2026-06-29

Phase I clinical trial of peptide vaccine for advanced gastric and colorectal cancer

Active, not recruitingJPRN-UMIN000004572

Tokyo Women's Medical UniversityAdvanced or recurrent gastric and colorectal cancer

Start: 2009-08-01Target: 9Updated: 2026-06-29